13D/13G Filings - BIOTECHNOLOGY VALUE FUND L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...12, 13, 14, 15, 16, 17, 18, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-07-06
5:01 pm
Purchase
2021-06-25 13G 4D Molecular Therapeutics, Inc.
FDMT
BIOTECHNOLOGY VALUE FUND L P 2,005,862
7.500%
2,005,862increase
(New Position)
Filing
History
2021-05-25
5:22 pm
Purchase
2021-05-21 13D Rain Enhancement Technologies Holdco Inc
RAIN
BIOTECHNOLOGY VALUE FUND L P 1,945,949
13.000%
93,438increase
(+5.04%)
Filing
History
2021-05-17
4:49 pm
Purchase
2021-05-06 13G Revolution Medicines, Inc.
RVMD
BIOTECHNOLOGY VALUE FUND L P 3,757,049
5.100%
3,757,049increase
(New Position)
Filing
History
2021-05-03
5:19 pm
Sale
2021-04-29 13G CytomX Therapeutics, Inc.
CTMX
BIOTECHNOLOGY VALUE FUND L P 2,919,471
4.500%
-2,657,000decrease
(-47.65%)
Filing
History
2021-04-29
4:29 pm
Sale
2021-04-27 13G IDEAYA Biosciences, Inc.
IDYA
BIOTECHNOLOGY VALUE FUND L P 1,787,559
5.400%
-1,439,210decrease
(-44.60%)
Filing
History
2021-04-28
09:26 am
Purchase
2021-04-23 13D Rain Enhancement Technologies Holdco Inc
RAIN
BIOTECHNOLOGY VALUE FUND L P 1,852,511
13.000%
1,852,511increase
(New Position)
Filing
History
2021-04-15
4:11 pm
Purchase
2021-04-13 13G Ovid Therapeutics Inc.
OVID
BIOTECHNOLOGY VALUE FUND L P 6,631,051
10.100%
2,109,000increase
(+46.64%)
Filing
History
2021-04-15
4:06 pm
Purchase
2021-04-13 13G ContraFect Corporation
CFRX
BIOTECHNOLOGY VALUE FUND L P 49,654
10.100%
13,292increase
(+36.56%)
Filing
History
2021-04-05
5:03 pm
Purchase
2021-03-26 13G Ikena Oncology, Inc.
IKNA
BIOTECHNOLOGY VALUE FUND L P 1,599,658
5.100%
1,599,658increase
(New Position)
Filing
History
2021-04-02
5:16 pm
Sale
2021-03-31 13D XOMA Corporation
XOMA
BIOTECHNOLOGY VALUE FUND L P 3,530,543
31.400%
-651,700decrease
(-15.58%)
Filing
History
2021-03-16
5:18 pm
Purchase
2021-03-12 13G Repare Therapeutics Inc.
RPTX
BIOTECHNOLOGY VALUE FUND L P 3,722,398
10.100%
750,207increase
(+25.24%)
Filing
History
2021-03-15
07:55 am
Purchase
2021-03-10 13D CTI BioPharma Corp.
CTIC
BIOTECHNOLOGY VALUE FUND L P 17,123,023
19.990%
4,369,333increase
(+34.26%)
Filing
History
2021-03-09
9:40 pm
Unchanged
2021-03-08 13G PHAXIAM Therapeutics S.A.
PHXM
BIOTECHNOLOGY VALUE FUND L P 40,819
19.300%
0
(Unchanged)
Filing
History
2021-03-08
4:54 pm
Purchase
2021-03-04 13G FIVE PRIME THERAPEUTICS INC
FPRX
BIOTECHNOLOGY VALUE FUND L P 6,338,678
13.800%
3,200,000increase
(+101.95%)
Filing
History
2021-03-05
4:33 pm
Purchase
2020-10-14 13G 5:01 Acquisition Corp.
FVAM
BIOTECHNOLOGY VALUE FUND L P 500,000
5.800%
500,000increase
(New Position)
Filing
History
2021-02-19
5:10 pm
Unchanged
2021-02-17 13G Infinity Pharmaceuticals, Inc.
INFIQ
BIOTECHNOLOGY VALUE FUND L P 8,383,645
9.960%
0
(Unchanged)
Filing
History
2021-02-16
4:30 pm
Sale
2021-02-11 13D Infinity Pharmaceuticals, Inc.
INFIQ
BIOTECHNOLOGY VALUE FUND L P 8,383,645
13.100%
-2,343,323decrease
(-21.85%)
Filing
History
2021-02-16
4:17 pm
Sale
2020-12-31 13G NOVUS THERAPEUTICS INC
NVUS
BIOTECHNOLOGY VALUE FUND L P 1,503,121
9.990%
-14,918decrease
(-0.98%)
Filing
History
2021-02-12
9:17 pm
Purchase
2020-12-31 13G Protagonist Therapeutics, Inc.
PTGX
BIOTECHNOLOGY VALUE FUND L P 4,274,965
9.990%
1,942,335increase
(+83.27%)
Filing
History
2021-02-12
8:57 pm
Purchase
2020-12-31 13G X4 Pharmaceuticals, Inc.
XFOR
BIOTECHNOLOGY VALUE FUND L P 57,321
9.990%
1,971increase
(+3.56%)
Filing
History
Goto Prev, 0, 1, ...12, 13, 14, 15, 16, 17, 18, Next